Inflammatory and immune reactions associated with stratum corneum and neutrophils in sterile pustular dermatoses

Tohoku Journal of Experimental Medicine

Volumn 190, Issue 4, 2000, Pages 239-248

  Terui, Tadashi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokines; Keratinocytes; Neutrophils; Psoriasis; T cells

Indexed keywords

DERMATITIS; EPIDERMIS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; NEUTROPHIL; PATHOPHYSIOLOGY; PSORIASIS; REVIEW;

DERMATITIS; EPIDERMIS; HUMANS; IMMUNE SYSTEM; NEUTROPHILS; PSORIASIS;

EID: 0034170714     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.190.239     Document Type: Review

References (66)

1. Barker, J.N.W.N., Jones, M.L., Mitra, R.S., Crockett-Torabe, E., Fantone, J.C., Kunkel, S.L., Warren, J.S., Dixit, V.M. & Nickoloff, B.J. (1991a) Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am. J. Pathol., 139, 869-876.
2. Barker, J.N., Karabin, G.D., Stoof, T.J., Sarma, V.J., Dixit, V.M. & Nickoloff, B.J. (1991b) Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction. J. Dermatol. Sci., 2, 106-111.
3. Basset-Seguin, N., Caughman, W. & Yancey, K.B. (1990) A-431 cells and human keratinocytes synthesize and secrete the third component of complement. J. Invest. Dermatol., 95, 621-625.
4. Bazzoni, F., Cassatella, M.A., Rossi, M., Ceska, M., Dewald, B. & Baggiolini, M. (1991) Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J. Exp. Med., 173, 771-774.
5. Bergh, K., Iversen, O.-J. & Lysvand, H. (1993) Surprisingly high levels of anaphylatoxin C5a des Arg are extractable from psoriatic scales. Arch. Dermatol. Res., 285, 131-134.
6. Bonifati, C., Ameglio, F., Carducci, M., Sacerdoti, G., Pietravalle, M. & Fazio, M. (1994) Interleukin-1-beta, interleukin-6, and interferon-gamma in suction blister fluids of involved and uninvolved skin and in sera of psoriatic patients. Acta Derm. Venereol. (Stockh), Suppl. 186, 23-24.
7. Chertov, O., Michiel, D.F., Xu, L., Wang, J.M., Tani,. K., Murphy, W.J., Longo, D.L., Taub, D.D. & Oppenheim, J.J. (1996) Identification of defensin-1, defensin-2, and CAP34/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem., 271, 2935-2940.
8. Cicco, N.A., Lindemann, A., Content, J., Vandenbussche, P., Lubbert, M., Gauss, J., Mertelsmann, R. & Hermann, F. (1990) Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-α. Blood, 75, 2049-2052.
9. Cox, A.J. & Watson, W. (1972) Histological variation in lesions of psoriasis. Arch. Dermatol., 106, 503-506.
10. Debets, R., Hengman, J.P.J.J., Troost, R.J.J., Benner, R. & Prens, E.P. (1995) Enhanced production of biologically active interleukin-1β and interleukin-1β by psoriatic epidermal cells ex vivo: Evidence of increased cytosolic interleukin-1β levels and facilitated interleukin-1 release. Eur. J. Immunol., 25, 1624-1630.
11. De Gendt, C.M., de Clerck, L.S., Bridts, C.H., Van Osselaer, N. & Stevens, E.J. (1996) Relationship between inerleukin-8 and neutrophil adhesion molecules in rheumatoid arthritis. Rheumatol. Int., 16, 169-173.
12. Dubravec, D.B., Spriggs, D.R., Mannick, J.A. & Rodrick, M.L. (1990) Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor α. Proc. Natl. Acad. Sci. USA, 87, 6758-6761.
13. Eedy, D.J., Burrows, D., Bridges, J.M. & Jones, F.G.C. (1990) Clearance of severe psoriasis after allogeneic bone marrow transplantation. BMJ, 300, 908.
14. Elder, J.T., Fisher, G.J., Lindquist, P.B., Bennett, G.L., Pittelkow, M.R., Coffey, R.J., Jr., Ellingsworth, L., Derynck, R. & Voorhees, J.J. (1989) Overexpression of transforming growth factor α in psoriatic epidermis. Science, 243, 811-814.
15. Ellis, C.N., Gorsulowsky, D.C., Hamilton, T.A., Billings, J.K., Brown, M.D., Headington, J.T., Cooper, K.D., Baadsgaard, O., Duell, E.A., Annesley, T.M., Turcotte, J.G. & Voorhees, J.J. (1986) Cyclosporin improves psoriasis in a double-blind study. JAMA, 256, 3110-3116.
16. Ellis, C.N., Fradin, M.S., Messana, J.M., Brown, M.D., Siegel, M.T., Hartley, A.H., Rocher, L.L., Wheeler, S., Hamilton, T.A., Parish, T.G., Ellis-Madu, M., Duell, E., Annesle, T.M., Cooper, K.D. & Voorhees, J.J. (1991) Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N. Engl. J. Med., 324, 277-284.
17. Fanger, N.A., Liu, C., Guyre, P.M., Wardwell, K., O'Neil, J., Guo, T.L., Christian, T. P., Mudzinski, S.P. & Gosselin, E.J. (1997) Activation of human T cells by major histocompatibility complex class II expressing neutrophils: Proliferation in the presence of superantigen, but not tetanus toxoid. Blood, 89, 4128-4135.
18. Fincham, N.J., Camp, R.D., Gearing, A.J., Bird, C.R. & Cunningham, F.M. (1988) Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterization. J. Immunol., 140, 4294-4299.
19. Fleming, C.J., Holme E.R. & Mackie R.M. (1996) Systemic complement activation in psoriasis vulgaris. Clin. Exp. Dermatol., 21, 415-418.
20. Gardembas-Pain, M., Ifrash, N., Foussard, C., Boasson, M., Saint Andre, J.P. & Verret, J.L. (1990) Psoriasis after allogeneic bone marrow transplantation. Arch. Dermatol., 126, 1523.
21. Gillitzer, R., Ritter, U., Spandau, U., Goebeler, M. & Brocker, E.-B. (1996) Differential expression of GRO-α and IL-8 mRNA in psoriasis: A model for neutrophil migration and accumulation in vivo. J. Invest. Dermatol., 107, 778-782.
22. Gosselin, E.J., Wardwell, K., Rigby, W.F. & Guyre, P.M. (1993) Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-γ, and IL-3. J. Immunol., 151, 1482-1490.
23. Grossman, R.M., Krueger, J., Yourish, D., Granelli-Piperno, A., Murphy, D.P., May, L. T., Kupper, T.S., Shegal, P.B. & Gottlieb, A.B. (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured keratinocytes. Proc. Natl. Acad. Sci. USA, 86, 6367-6371.
24. Gottlieb, A.B., Luster, A.D., Posnett, D.N. & Carter, D.M. (1988) Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J. Exp. Med., 168, 941-948.
25. Gottlieb, S.L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T.G., Gottlieb, A. B. & Krueger, J.G. (1995) Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocytes, pathogenic basis. Nature Med., 1, 442-447.
26. Jack, R.M. & Fearon, D.T. (1988) Selective synthesis of mRNA and proteins by human peripheral blood neutrophils. J. Immunol., 140, 4286-4293.
27. Kato, T., Iizawa, O., Terui, T. & Tagami, H. (1990) Lucigenin-dependent chemiluminescence in neutrophils stimulated with stratum corneum sheet. Arch. Dermatol. Res., 282, 208-209.
28. Kato, T., Hara, M., Iizawa, O., Terui, T. & Tagami, H. (1991) Interaction between human neutrophils and corneocytes: corneocyte-induced respiratory burst of neutrophils assessed by chemiluminescence. Inflammation, 25, 213-221.
29. Kock, A.E., Kunkel, S.L., Shah, M.R., Hosaka, S., Halloran, M.M., Haines, G.K., Burdick, M.D., Pope, R.M. & Strieter, R.M. (1995) Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis. J. Immunol., 155, 3660-3666.
30. Kudo, C., Yamashita, T., Araki, A., Terashita, M., Watanabe, T., Atsumi, M., Tamura, M. & Sendo, F. (1993) Modulation of in vivo immune responses by selective depletion of neutrophils using monoclonal antibody, RP-3. J. Immunol., 150, 3728-3738.
31. Kulke, R., Todt-Pingel, I., Rademacher, D., Rowert, J., Schröder, J.-M. & Christophers, E. (1996) Co-localized overexpression of GRO-α and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions. J. Invest. Dermatol., 106, 526-530.
32. Kuramoto, Y. & Tagami, H. (1989) Histopathologic pattern analysis of human intracutaneous tuberculin reaction. Am. J. Dermatopathol., 11, 329-337.
33. Larsen, C.G., Anderson, A.O., Appella, E., Oppenheim, J.J. & Matsushima, K. (1989) The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science, 243, 1464-1466.
34. Lopez, A.F., Williamson, D.J., Gamble, J.R., Begley, C.G., Harlan, J.M., Klebanoff, S. J., Walterdorph, A., Wong, G., Clark, S.C. & Vadas, M.A. (1986) Recombinant human granulocyte-macrophage colony-stimulating factor stimulate in vitro mature human neutrophil and eosinophil functions, surface receptor expression, and survival. J. Clin. Invest., 78, 1220-1228.
35. Lord, P.C., Wilmoth, L.M., Mizel, S.B. & McCall, C.E. (1991) Expression of interleukin-1 α and β genes by human polymorphonuclear leukocytes. J. Clin. Invest., 87, 1312-1321.
36. Lundqvist, E.N. & Egelrud, T. (1997) Biologically active, alternatively processed interleukin-1β in psoriatic scales. Eur. J. Immunol., 27, 2165-2171.
37. Marley, W.M., Belew, P.W., Rosenberg, E.M., Urmson, J.R., Stitzel, A.E. & Spitzer, R. E. (1982) Abnormalities in the alternative pathway of complement in psoriasis. Clin. Exp. Dermatol., 7, 387-396.
38. Matsumoto, S., Takei, M., Moriyama, M. & Imanishi, H. (1987) Enhancement of Ia-like antigen expression by interferon-γ in polymorphonuclear leukocytes. Chem. Pharm. Bull., 34, 436-439.
39. Morhenn, V.B., Abel, E.A. & Mahle, G. (1982) Expression of HLA-DR antigen in skin from patients with psoriasis. J. Invest. Dermatol., 78, 165-168.
40. Mudzinski, S.P., Christian, T.P., Guo, E., Cirenza, E., Hazlett, K.R. & Gosselin, E.J. (1995) Expression of HLA-DR (major histocompatibility complex II) on neutrophils from patients treated with granulocytes-macrophage colony-stimulating factor for mobilization of stem cells [letter]. Blood, 86, 2452-2453.
41. Neuman, E., Huleatt, J.W., Vargas, H., Rupp, E.E. & Jack, R.M. (1992) Regulation of MHC class I synthesis and expression by human neutrophils. J. Immunol., 148, 3520-3527.
42. Nicolas, J.-F., Chamchick, N., Thivolet, J., Wijdenes, J., Morel, P. & Revillard, J.P. (1991) CD4 antibody treatment of severe psoriasis [letter]. Lancet, 338, 321.
43. Ohkohchi, K., Torinuki, W. & Tagami, H. (1989) Plasma concentrations of complement-modulating proteins (C1 inhibitor, C4 binding protein, factor H and factor I) inflammatory dermatoses wit special reference to psoriasis. Dermatologica, Suppl. 1, 179, 30-34.
44. Petroni, K.C., Shen, L. & Guyre, P.M. (1988) Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-γ and glucocorticoids. J. Immunol., 140, 3467-3472.
45. Pinkus, H. & Mehregan, A.H. (1966) The primary histologic lesion of seborrheic dermatitis and psoriasis. J. Invest. Dermatol., 46, 109-116.
46. Poizot-Martin, I., Dhiver, C., Mawas, C., Olive, D. & Gastaut, J.A. (1991) Are CD4 antibodies and peptide T new treatments for psoriasis ? [letter]. Lancet, 337, 1477.
47. Prinz, J.C., Grob, B., Vollmer, S., Trommler, P., Strobel, I., Meurer, M. & Plewig, G. (1994) T cell clones from psoriasis skin lesions can promote proliferation in vitro via secreted products. Eur. J. Immunol., 24, 593-598.
48. Ragaz, A. & Ackerman, A.B. (1979) Evolution, maturation, and regression of lesions of psoriasis. Am. J. Dermatopathol., 1, 199-214.
49. Reinisch, W., Tillinger, W., Lichtenberger, C., Gangl, A., Willheim, M., Scheiner, O. & Steger, G. (1996) In vivo induction of HLA-DR on human neutrophils in patients treated with interferon-α [letter]. Blood, 87, 3068.
50. Rosenberg, E.W., Noah, P.W., Wyatt, R.J., Jones, R.M. & Kolb, W.P. (1990) Complement activation in psoriasis. Clin. Exp. Dermatol., 15: 16-20.
51. Sohlaak, J.F., Buslau, M., Jochum, W., Hermann, E., Girndt, M., Gallati, H., Buschenfelde, K.-H. & Fleischer, B. (1994) T cells involved in psoriasis vulgaris belong to the Th1 subset. J. Invest. Dermatol., 102, 145-149.
52. Schröder, J.-M. & Christophers, E. (1986) Identification of C5a des arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J. Invest. Dermatol., 87, 53-58.
53. Soltani, K. & Van Scott, E.J. (1972) Patterns of sequence of tissue changes in incipient and evolving lesions of psoriasis. Arch. Dermatol., 106, 484-490.
54. Shirafuji, N., Matsuda, S., Ogura, H., Tani, K., Kodo, H., Ozawa, K., Nagata, S., Asano, S. & Takaku, F. (1990) Granulocyte colony-stimulating factor stimulates human mature neutrophilic granulocytes to produce interferon-α. Blood, 75, 17-19.
55. Smith, W.B., Guida, I., Sun, Q., Korpelainen, E.I., van den Heuvel, C., Gillis, D., Hawrylowicz, C.M., Vadas, M.A. & Lopez, A.F. (1995) Neutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression. Blood, 86, 3938-3944.
56. + subsets. J. Invest. Dermatol., 111, 1072-1078.
57. Tagami, H., Iwatsuki, K. & Takematsu, H. (1987) Psoriasis and leukocyte chemotaxis. J. Invest. Dermatol., 88, 18S-23S.
58. Takematsu, H., Ohkohchi, K. & Tagami, H. (1986) Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses. Br. J. Dermatol., 114, 1-6.
59. Takematsu, H. & Tagami, H. (1993) Quantitation of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch. Dermatol., 129, 74-80.
60. Terui, T., Aiba, S., Kato, T., Tanaka, T. & Tagami, H. (1987) HLA-DR antigen expression on keratinocytes in highly inflamed parts of psoriatic lesions. Br. J. Dermatol., 116, 87-93.
61. Terui, T., Rokugo, M., Kato, T. & Tagami, H. (1989a) Analysis of the pro inflammatory property of epidermal cyst contents: Chemotactic C5a anaphylatoxin generation. Arch. Dermatol. Res., 281, 331-34.
62. Terui, T., Kato, T. & Tagami, H. (1989b) Stratum corneum activation of complement through the antibody-independent alternative pathway. J. Invest. Dermatol., 92, 593-597.
63. Terui, T, Zhen, Y.-X., Kato, T. & Tagami, H. (1995) Mechanism of human polymorphonuclear leukocyte adhesion to serum-treated corneocytes. J. Invest. Dermatol., 104, 297-301.
64. Terui, T., Ishii, K., Ozawa, M., Tabata, N., Kato, T. & Tagami, H. (1997) C3 production of cultured human epidermal keratinocytes is enhanced by IFNγ and TNFα through different pathways. J. Invest. Dermatol., 108, 62-67.
65. Van de Kerchief, P.C.M. & Lammers, A.M. (1987) Intraepidermal accumulation of polymorphonuclear leukocytes in chronic stable plaque psoriasis. Dermatologica, 174, 224-227.
66. Weinshenker, B.G., Bass, B.H., Eber, G.C. & Rice, G.P.A. (1989) Remission of psoriatic lesions with muromonab-CD3 (Orthoclone OKT3) treatment. J. Am. Acad. Dermatol., 20, 1132-1133.